HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.

Abstract
HER2-positive breast tumors are associated with a high risk of brain relapse. HER3 is thought to be an indispensible signaling substrate for HER2 (encoded by ERBB2) and is induced in breast cancer-brain metastases, though the molecular mechanisms by which this oncogenic dimer promotes the development of brain metastases are still elusive. We studied the effects of the HER3-HER2 ligand, heregulin (neuregulin-1, broadly expressed in the brain), on luminal breast cancer cell lines in vitro. Treatment of SKBr3 (ERBB2-amplified), MDA-MB-361 (ERBB2-amplified, metastatic brain tumor-derived) and MCF7 (HER2-positive, not ERBB2-amplified) cells with exogenous heregulin increased proliferation and adhesive potential, concomitant with induction of cyclin D1 and ICAM-1, and suppression of p27. All three cell lines invaded through matrigel toward a heregulin chemotactic signal in transwell experiments, associated with activation of extracellular cathepsin B and matrix metalloproteinase-9 (MMP-9). Moreover, heregulin induced breast cancer cell transmigration across a tight barrier of primary human brain microvascular endothelia. This was dependent on the activity of HER2, HER3 and MMPs, and was completely abrogated by combination HER2-HER3 blockade using Herceptin® and the humanized HER3 monoclonal antibody, EV20. Collectively these data suggest mechanisms by which the HER3-HER2 dimer promotes development of metastatic tumors in the heregulin-rich brain microenvironment.
AuthorsMajid Momeny, Jodi M Saunus, Flavia Marturana, Amy E McCart Reed, Debra Black, Gianluca Sala, Stefano Iacobelli, Jane D Holland, Dihua Yu, Leonard Da Silva, Peter T Simpson, Kum Kum Khanna, Georgia Chenevix-Trench, Sunil R Lakhani
JournalOncotarget (Oncotarget) Vol. 6 Issue 6 Pg. 3932-46 (Feb 28 2015) ISSN: 1949-2553 [Electronic] United States
PMID25668816 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NRG1 protein, human
  • Neuregulin-1
  • ERBB2 protein, human
  • ERBB3 protein, human
  • Receptor, ErbB-2
  • Receptor, ErbB-3
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Blood-Brain Barrier (enzymology, metabolism, pathology)
  • Brain (blood supply)
  • Breast Neoplasms (enzymology, genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Movement (physiology)
  • Endothelial Cells (metabolism)
  • Female
  • Humans
  • MCF-7 Cells
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Neuregulin-1 (metabolism)
  • Receptor, ErbB-2 (metabolism)
  • Receptor, ErbB-3 (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: